Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Department of General Practice, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Eur J Surg Oncol. 2024 Jun;50(6):108262. doi: 10.1016/j.ejso.2024.108262. Epub 2024 Mar 15.
Endoscopic therapy (ET) of gastrointestinal stromal tumors (GIST) has become a viable treatment. We intended to compare long-term outcomes of ET versus surgical resection for 2-5 cm GIST using the Surveillance, Epidemiology, and End Results (SEER) database.
A multicenter retrospective study was conducted to compare the long-term outcomes of patients treated with ET and surgical resection for GIST. The multivariate Cox proportional hazards models were used to identify predictors for patients survival. To balance the clinicopathologic characteristics, a 1:1 propensity score matching (PSM) was utilized.
A total of 749 patients with 2-5 cm GIST were enrolled, of whom 113 accepted ET and 636 underwent surgical resection. Before PSM, there was no significant difference in long-term outcomes between ET and surgical resection (5-year overall survival (OS): 93.5% vs. 91.6%, P=0.374; 5-year cancer-specific survival (CSS): 99.1% vs. 96.5%, P=0.546; 10-year OS: 71.1% vs. 78.2%, P=0.374; 10-year CSS: 93.6% vs. 92.7%, P=0.546). After adjusting for the relevant variables using the multivariable Cox proportional hazards models, we observed that the ET and surgical resection groups were similar in OS (HR 0.726, 95%CI 0.457-1.153, P=0.175) and CSS (HR 1.286, 95%CI 0.474-3.488, P=0.621). After PSM, the long-term OS and CSS of patients with 2-5 cm GIST after ET and surgical resection were comparable.
We found that the long-term survival of patients with 2-5 cm gastric GIST after ET and surgical resection were comparable. Further high-quality studies are needed to confirm the role of ET in 2-5 cm GIST.
内镜治疗(ET)已成为胃肠道间质瘤(GIST)的一种可行的治疗方法。本研究旨在利用监测、流行病学和最终结果(SEER)数据库比较 2-5cm GIST 的 ET 与手术切除的长期疗效。
采用多中心回顾性研究比较接受 ET 和手术切除的 GIST 患者的长期疗效。采用多变量 Cox 比例风险模型确定患者生存的预测因素。为了平衡临床病理特征,采用 1:1 倾向评分匹配(PSM)。
共纳入 749 例 2-5cm GIST 患者,其中 113 例接受 ET,636 例接受手术切除。在 PSM 之前,ET 与手术切除的长期疗效无显著差异(5 年总生存率(OS):93.5% vs. 91.6%,P=0.374;5 年癌症特异性生存率(CSS):99.1% vs. 96.5%,P=0.546;10 年 OS:71.1% vs. 78.2%,P=0.374;10 年 CSS:93.6% vs. 92.7%,P=0.546)。使用多变量 Cox 比例风险模型调整相关变量后,我们发现 ET 组和手术切除组的 OS(HR 0.726,95%CI 0.457-1.153,P=0.175)和 CSS(HR 1.286,95%CI 0.474-3.488,P=0.621)相似。PSM 后,2-5cm GIST 患者 ET 和手术切除后长期 OS 和 CSS 相似。
我们发现 2-5cm 胃 GIST 患者 ET 和手术切除后的长期生存相当。需要进一步开展高质量的研究来证实 ET 在 2-5cm GIST 中的作用。